Co-Founder & Chief Executive Officer
Sana Alajmovic is a Board Member, as well as Co-Founder and Chief Executive Officer of Sigrid Therapeutics AB, with successful experience in commercializing research and discovery by establishing partnership with global top tier biopharmaceutical actors.
Sana has diverse experience in business development and management within the Life Science industry. Her previous positions include Head of Business Development for Drug Delivery at Nanologica AB, Business Development Manager within the Serendipity Innovations Group and Business Development Manager for the Swedish-American Life Science Summit. Before joining the Life Science industry, Sana was Managing Director for the venture capital firm Curitas in the Procuritas Group, Operations Manager for the charity foundation Chelha and Assistant Events & Marketing Manager at the Swedish-American Chamber of Commerce in New York. She was named one of Sweden’s 101 Super Talents by the leading Swedish business magazine Veckans Affärer in 2012.
Sana received her Bachelor of Science (BSc) in Business and Economics from the Stockholm School of Economics.